3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate

C100H106N34O10 — CID 164982783

IUPAC3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate
SMILESCCC(CO)N(C)c1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2-c1cccnc1.COC(=O)CNc1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2-c1ccncc1.O=C(O)C(CC1CC1)n1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cn4)CC3)nc21.Oc1ccc(N2CCN(c3nc(-n4ncc5ccccc54)c4ncn(C5CCOC5)c4n3)CC2)nc1
InChIInChI=1S/C27H27N9O3.C25H25N9O2.C25H30N8O2.C23H24N8O3/c37-19-7-8-22(28-15-19)33-9-11-34(12-10-33)27-31-24-23(29-16-35(24)21(26(38)39)13-17-5-6-17)25(32-27)36-20-4-2-1-3-18(20)14-30-36;35-19-5-6-21(26-14-19)31-8-10-32(11-9-31)25-29-23-22(27-16-33(23)18-7-12-36-15-18)24(30-25)34-20-4-2-1-3-17(20)13-28-34;1-3-18(16-34)30(2)23-22-24(33(17-27-22)20-5-4-10-26-15-20)29-25(28-23)32-13-11-31(12-14-32)19-6-8-21(35)9-7-19;1-34-19(33)14-25-21-20-22(31(15-26-20)17-6-8-24-9-7-17)28-23(27-21)30-12-10-29(11-13-30)16-2-4-18(32)5-3-16/h1-4,7-8,14-17,21,37H,5-6,9-13H2,(H,38,39);1-6,13-14,16,18,35H,7-12,15H2;4-10,15,17-18,34-35H,3,11-14,16H2,1-2H3;2-9,15,32H,10-14H2,1H3,(H,25,27,28)
InChIKeyFSOXHGDRERXBNA-UHFFFAOYSA-N
MW1944.18 g/mol
LogP9.85
Rot. Bonds24

About 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate

3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate (PubChem CID 164982783) has the molecular formula C100H106N34O10 and a molecular weight of 1944.18 g/mol. Its IUPAC name is 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate.

Molecular Properties

Compound Name3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate
PubChem CID164982783
Molecular FormulaC100H106N34O10
Molecular Weight1944.18 g/mol
Exact Mass1942.88
IUPAC Name3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate
SMILESCCC(CO)N(C)c1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2-c1cccnc1.COC(=O)CNc1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2-c1ccncc1.O=C(O)C(CC1CC1)n1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cn4)CC3)nc21.Oc1ccc(N2CCN(c3nc(-n4ncc5ccccc54)c4ncn(C5CCOC5)c4n3)CC2)nc1
InChIInChI=1S/C27H27N9O3.C25H25N9O2.C25H30N8O2.C23H24N8O3/c37-19-7-8-22(28-15-19)33-9-11-34(12-10-33)27-31-24-23(29-16-35(24)21(26(38)39)13-17-5-6-17)25(32-27)36-20-4-2-1-3-18(20)14-30-36;35-19-5-6-21(26-14-19)31-8-10-32(11-9-31)25-29-23-22(27-16-33(23)18-7-12-36-15-18)24(30-25)34-20-4-2-1-3-17(20)13-28-34;1-3-18(16-34)30(2)23-22-24(33(17-27-22)20-5-4-10-26-15-20)29-25(28-23)32-13-11-31(12-14-32)19-6-8-21(35)9-7-19;1-34-19(33)14-25-21-20-22(31(15-26-20)17-6-8-24-9-7-17)28-23(27-21)30-12-10-29(11-13-30)16-2-4-18(32)5-3-16/h1-4,7-8,14-17,21,37H,5-6,9-13H2,(H,38,39);1-6,13-14,16,18,35H,7-12,15H2;4-10,15,17-18,34-35H,3,11-14,16H2,1-2H3;2-9,15,32H,10-14H2,1H3,(H,25,27,28)
InChIKeyFSOXHGDRERXBNA-UHFFFAOYSA-N
XLogP9.85
TPSA476.77 Ų
H-Bond Donors7
H-Bond Acceptors43
Rotatable Bonds24
Heavy Atoms144
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001944.18
LogP ≤ 59.85
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1043

Analyze 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate?
The IUPAC name of 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate (CID 164982783) is 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate.
What is the SMILES notation for 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate?
The canonical SMILES for 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate is CCC(CO)N(C)c1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2-c1cccnc1.COC(=O)CNc1nc(N2CCN(c3ccc(O)cc3)CC2)nc2c1ncn2-c1ccncc1.O=C(O)C(CC1CC1)n1cnc2c(-n3ncc4ccccc43)nc(N3CCN(c4ccc(O)cn4)CC3)nc21.Oc1ccc(N2CCN(c3nc(-n4ncc5ccccc54)c4ncn(C5CCOC5)c4n3)CC2)nc1.
What is the InChIKey of 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate?
The InChIKey is FSOXHGDRERXBNA-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27N9O3.C25H25N9O2.C25H30N8O2.C23H24N8O3/c37-19-7-8-22(28-15-19)33-9-11-34(12-10-33)27-31-24-23(29-16-35(24)21(26(38)39)13-17-5-6-17)25(32-27)36-20-4-2-1-3-18(20)14-30-36;35-19-5-6-21(26-14-19)31-8-10-32(11-9-31)25-29-23-22(27-16-33(23)18-7-12-36-15-18)24(30-25)34-20-4-2-1-3-17(20)13-28-34;1-3-18(16-34)30(2)23-22-24(33(17-27-22)20-5-4-10-26-15-20)29-25(28-23)32-13-11-31(12-14-32)19-6-8-21(35)9-7-19;1-34-19(33)14-25-21-20-22(31(15-26-20)17-6-8-24-9-7-17)28-23(27-21)30-12-10-29(11-13-30)16-2-4-18(32)5-3-16/h1-4,7-8,14-17,21,37H,5-6,9-13H2,(H,38,39);1-6,13-14,16,18,35H,7-12,15H2;4-10,15,17-18,34-35H,3,11-14,16H2,1-2H3;2-9,15,32H,10-14H2,1H3,(H,25,27,28).
What are the key properties of 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate?
3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate has a molecular weight of 1944.18 g/mol, XLogP of 9.85, 24 rotatable bonds, 7 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 3-cyclopropyl-2-[2-[4-(5-hydroxy-2-pyridinyl)piperazin-1-yl]-6-indazol-1-ylpurin-9-yl]propanoic acid;4-[4-[6-[1-hydroxybutan-2-yl(methyl)amino]-9-pyridin-3-ylpurin-2-yl]piperazin-1-yl]phenol;6-[4-[6-indazol-1-yl-9-(oxolan-3-yl)purin-2-yl]piperazin-1-yl]pyridin-3-ol;methyl 2-[[2-[4-(4-hydroxyphenyl)piperazin-1-yl]-9-pyridin-4-ylpurin-6-yl]amino]acetate is sourced from PubChem (CID 164982783), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).